UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 465

Sortiert nach

Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

Journal of clinical oncology, 2012-01, Vol.30 (2), p.191-199

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients

Annals of nuclear medicine, 2019-12, Vol.33 (12), p.945-954

2019

Link zum Volltext

Verfügbarkeit prüfen

Digital Implementation of Oscillatory Neural Network for Image Recognition Applications

Frontiers in neuroscience, 2021-08, Vol.15, p.713054-713054

2021

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis

European journal of case reports in internal medicine, 2021-04, Vol.8 (4), p.002425-002425

2021

Link zum Volltext

Verfügbarkeit prüfen

A mixed-signal oscillatory neural network for scalable analog computations in phase domain

Neuromorphic computing and engineering, 2023-09, Vol.3 (3), p.34004

2023

Link zum Volltext

Verfügbarkeit prüfen

Oligometastatic Disease Detection with 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact

Cancers, 2021-10, Vol.13 (19), p.4982

2021

Link zum Volltext

Verfügbarkeit prüfen

A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma

Diagnostics (Basel), 2022-02, Vol.12 (2), p.539

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer

Molecular and clinical oncology, 2016-06, Vol.4 (6), p.1063-1067

2016

Link zum Volltext

Verfügbarkeit prüfen

Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study

Therapeutic advances in urology, 2017-07, Vol.9 (7), p.179-190

2017

Link zum Volltext

Verfügbarkeit prüfen

A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer

Therapeutic advances in urology, 2015-06, Vol.7 (3), p.116-124

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular targeted therapies in breast cancer: Where are we now?

The international journal of biochemistry & cell biology, 2007-01, Vol.39 (7-8), p.1375-1387

2007

Link zum Volltext

Verfügbarkeit prüfen

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

The New England journal of medicine, 2019-12, Vol.381 (26), p.2506-2518

2019

Link zum Volltext

Verfügbarkeit prüfen

68Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy

The Journal of nuclear medicine (1978), 2022-08, Vol.63 (8), p.1191-1198

2022

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab

Clinical nuclear medicine, 2020-08, Vol.45 (8), p.e381

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical impact of 68Ga‐prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate‐specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach

BJU international, 2017-08, Vol.120 (2), p.197-203

2017

Link zum Volltext

Verfügbarkeit prüfen

Building an “Escape Portal” with Tethers Fixed in Asteroids

The Journal of the astronautical sciences, 2018-09, Vol.65 (3), p.355-375

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours

European journal of cancer (1990), 2012-01, Vol.48 (2), p.179-186

2012

Link zum Volltext

Verfügbarkeit prüfen

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

The lancet oncology, 2015-01, Vol.16 (1), p.76-86

2015

Link zum Volltext

Verfügbarkeit prüfen

How Frequency Injection Locking Can Train Oscillatory Neural Networks to Compute in Phase

IEEE transaction on neural networks and learning systems, 2022-05, Vol.33 (5), p.1996-2009

2022

Link zum Volltext
Volltext

68 Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy

Journal of Nuclear Medicine, 2022-08, Vol.63 (8), p.1191-1198

2022

Link zum Volltext

Verfügbarkeit prüfen

Avelumab as neoadjuvant therapy in subjects with muscle-invasive urothelial carcinoma (AURA trial)

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.TPS535-TPS535

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 465

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(382)
Mit Volltextzugriff
(440)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(321)
Life Sciences & Biomedicine
(198)
Humans
(124)
Physical Sciences
(98)
Technology
(87)
Life Sciences
(85)
Female
(71)
Male
(71)
Physics
(71)
Condensed Matter
(59)
Materials Science
(57)
Computer Science
(51)
Middle Aged
(51)
Aged
(48)
Adult
(46)
Engineering Sciences
(43)
Chemistry
(42)
Oncology
(40)
Physics, Applied
(38)
Computer Science, Artificial Intelligence
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)

Digital Implementation of Oscillatory Neural Network for Image Recognition Applications

Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis

A mixed-signal oscillatory neural network for scalable analog computations in phase domain

Oligometastatic Disease Detection with 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact

A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer

Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study

A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer

Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program

Molecular targeted therapies in breast cancer: Where are we now?

Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

68Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy

COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab

Clinical impact of 68Ga‐prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate‐specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach

Building an “Escape Portal” with Tethers Fixed in Asteroids

A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

How Frequency Injection Locking Can Train Oscillatory Neural Networks to Compute in Phase

68 Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy

Avelumab as neoadjuvant therapy in subjects with muscle-invasive urothelial carcinoma (AURA trial)

Suchergebnisse filtern